Skip to main content
Kathryn A. Peterson
( out of 42 reviews )

Kathryn A. Peterson, MD, MSci

Languages spoken: English

Clinical Locations

Primary Location

Sugar House Health Center

1280 E. Stringham Avenue
Salt Lake City , UT 84106

Farmington Health Center

165 N. University Ave.
Farmington , UT 84025

University of Utah Hospital

Gastroenterology Endoscopy Center
50 N Medical Dr
Salt Lake City , UT 84132

Kathryn Peterson, MD is Professor of Gastroenterology at University of Utah Health. She is certified by the American Board of Internal Medicine.

Dr. Peterson specializes in diagnosing and treating diseases of the digestive system including Eosiniphilic Esophagitis, Barrett’s Esophagus, and inflammatory bowel disease. She completed her medical degree at the University of Texas Southwestern, followed by residency and a fellowship at the University of Utah and a masters program in Epidemiology at Harvard University.

Board Certification

American Board of Internal Medicine (Sub: Gastroenterology)

Patient Rating

5.0 /5
( out of 42 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

The scale on which responses are measured is 1 to 5 with 5 being the best score.

Patient Comments

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

UH HOSPITALS AND CLINICS

Mine is a difficult case, but Dr Peterson has worked very hard to find a way to help me get better. I was ready to "release her" from being my doctor several months ago, but she wants to see it through. She is always looking for new treatment options for me and is very dedicated to my case.

UH HOSPITALS AND CLINICS

Dr Peterson is simply one of the best care providers I've ever had, regardless of specialty. She's engaged in every aspect of care and genuinely cares about outcome

UH HOSPITALS AND CLINICS

Dr. Kathryn Peterson is honestly the best doctor in the University of Utah health care system and the best GI I have ever had over the past 20 years. Her genuine care for her patients is unmatched. Her brilliance in her field is incredible. I've seen over 20 GIs around the US over the past 20 years. I would, without question, travel to see her to ensure continued care if I ever have to move.

UH HOSPITALS AND CLINICS

Kathryn Peterson is very down to earth and takes her time and effort to be personable with you while being very clear and kind.

UNIVERSITY HOSPITAL

Dr. Peterson is a thorough physician who takes time to explain what is going on with you and what treatment options are available to help with your condition and symptoms. She loves what she does and ensures she is up to date on the latest research for your condition. I highly recommend Dr. Peterson!

UH HOSPITALS AND CLINICS

Dr. Peterson took her time with me and listened. She was very thorough and had a good plan for me. She's incredibly knowledgeable and personable.

SUGAR HOUSE HEALTH CENTER

dr Peterson was the best doctor Ive ever seen. she spent a long time with me and I never felt rushed. it felt like she actually cared.

UH HOSPITALS AND CLINICS

Dr. Peterson is beyond amazing!! I am so lucky to have found such a smart and caring doctor.

SUGAR HOUSE HEALTH CENTER

Dr. Peterson is a remarkable doctor!

Kathryn Peterson, MD is Professor of Gastroenterology at University of Utah Health. She is certified by the American Board of Internal Medicine.

Dr. Peterson specializes in diagnosing and treating diseases of the digestive system including Eosiniphilic Esophagitis, Barrett’s Esophagus, and inflammatory bowel disease. She completed her medical degree at the University of Texas Southwestern, followed by residency and a fellowship at the University of Utah and a masters program in Epidemiology at Harvard University.

Board Certification and Academic Information

Academic Departments Internal Medicine -Adjunct Professor
Dermatology -Adjunct Assistant Professor
Academic Divisions Gastroenterology
Board Certification
American Board of Internal Medicine (Sub: Gastroenterology)

Education history

Undergraduate University of Delaware
Undergraduate Molecular Biology - Texas Tech University B.S.
Professional Medical Medicine - University of Texas Southwestern M.D.
Internship Internal Medicine - University of Utah School of Medicine Intern
Residency Internal Medicine - University of Utah School of Medicine Resident
Fellowship Gastroenterology - University of Utah School of Medicine Fellow
Graduate Training Epidemiology - Harvard University M.Sci.

Selected Publications

Journal Article

  1. Peterson K, Firszt R, Fang J, Wong J, Smith KR, Brady K (2016). Risk of Autoimmunity in EoE and Families: A Population-Based Cohort Study. The American journal of gastroenterology, 111(7), 926-32.
  2. Siebermair J, Suksaranjit P, McGann CJ, Peterson KA, Kheirkhahan M, Baher AA, Damal K, Wakili R, Marrouche NF, Wilson B (2019). Atrial fibrosis in non-atrial fibrillation individuals and prediction of atrial fibrillation by use of late gadolinium enhancement magnetic resonance imaging. Journal of cardiovascular electrophysiology, 30(4), 550-556.
  3. Frech TM, Fakoya L, Gawron AJ, Wong J, Scholand MB, Sawitzke A, Peterson (2017). Oesophageal disease in systemic sclerosis: does heritability play a role?. Clinical and experimental rheumatology, 35 Suppl 106(4), 86-88.
  4. Hirano I, Dellon ES, Hamilton JD, Collins MH, Peterson K, Chehade M, Schoepfer AM, Safroneeva E, Rothenberg ME, Falk GW, Assouline-Dayan Y, Zhao Q, Chen Z, Swanson BN, Pirozzi G, Mannent L, Graham NMH, Akinlade B, Stahl N, Yancopoulos GD, Radin (2019). Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis. Gastroenterology,
  5. Faigel DO, Eisen GM, Baron TH, Dominitz JA, Goldstein JL, Hirota WK, Jacobson BC, Johanson JF, Leighton JA, Mallery JS, Peterson KA, Raddawi HM, Varg JJ 2nd, Waring JP, Fanelli RD, Wheeler-Harbough J, Standards of Practice Committee. American Society for Gastrointestinal Endoscopy (2003). Tissue sampling and analysis. Gastrointestinal endoscopy, 57(7), 811-6.
  6. Faigel DO, Baron TH, Goldstein JL, Hirota WK, Jacobson BC, Johanson JF, Leighton JA, Mallery JS, Peterson KA, Waring JP, Fanelli RD, Wheeler-Harbaugh J, Standards Practice Committe, American Society for Gastrointestinal Endoscopy (2002). Guidelines for the use of deep sedation and anesthesia for GI endoscopy. Gastrointestinal endoscopy, 56(5), 613-7.
  7. Zimmermann N, Abonia JP, Dreskin SC, Akin C, Bolton S, Happel CS, Geller M, Larenas-Linnemann D, Nanda A, Peterson K, Wasan A, Wechsler J, Zhang S, Bernstein J (2021). Developing a standardized approach for assessing mast cells and eosinophils on tissue biopsies: A Work Group Report of the AAAAI Allergic Skin Diseases Committee. The Journal of allergy and clinical immunology,
  8. Robson J, Korgenski K, Parsons K, McClain A, Barbagelata C, Allen-Brady K, Patel R, O'Gorman M, Peterson K, Guthery (2019). Sensitivity and Specificity of Administrative Medical Coding for Pediatric Eosinophilic Esophagitis. Journal of pediatric gastroenterology and nutrition, 69(2), e49-e53.
  9. Robson J, Laborda T, Fitzgerald S, Andersen J, Peterson K, O'Gorman M, Guthery S, Bennett-Murphy (2019). Avoidant/Restrictive Food Intake Disorder in Diet-treated Children With Eosinophilic Esophagitis. Journal of pediatric gastroenterology and nutrition, 69(1), 57-60.
  10. Allred D, Frech TM, McComber C, Peterson K, Ortiz G, McNeill C, Broadbent L, Elorreaga N, Miller T, Scholand M (2017). Chronic Multiorgan Rare Disease: The Role of the Nurse Practitioner as a Leader of the Healthcare Team. The Journal of medical practice management, 32(6), 413-416.
  11. Padia R, Curtin K, Peterson K, Orlandi RR, Alt (2016). Eosinophilic esophagitis strongly linked to chronic rhinosinusitis. The Laryngoscope, 126(6), 1279-83.
  12. Saffari H, Kennedy A, Peterson KA, Gleich GJ, Pease LF 3r (2015). Non-invasive ultrasound to identify eosinophil granule proteins in eosinophilic esophagitis. Ultrasound in medicine & biology, 41(3), 884-9.
  13. Martin L, Mullaney S, Peche W, Peterson K, Chan S, Morton R, Wan Y, Zhang C, Presson AP, Emery B, Aston K, Jenkins T, Carrell D, Hotaling (2017). Population-based Semen Analysis Results and Fertility Among Patients With Inflammatory Bowel Disease: Results From Subfertility Health Assisted Reproduction and the Environment (SHARE) Study. Urology, 107, 114-119.
  14. Peterson KA, Gleich GJ, Limaye NS, Crispin H, Robson J, Fang J, Saffari H, Clayton F, Leiferman K (2019). Eosinophil granule major basic protein 1 deposition in eosinophilic esophagitis correlates with symptoms independent of eosinophil counts. Diseases of the esophagus, 32(11),
  15. Laing P, Bress AP, Fang J, Peterson K, Adler DG, Gawron A (2017). Trends in diagnoses after implementation of the Chicago classification for esophageal motility disorders (V3.0) for high-resolution manometry studies. Diseases of the esophagus, 30(12), 1-6.
  16. Johnson J, Affolter K, Boynton K, Chen X, Valentine J, Peterson (2018). CMV Disease in IBD: Comparison of Diagnostic Tests and Correlation with Disease Outcome. Inflammatory bowel diseases, 24(7), 1539-1546.
  17. COREOS Collaborators, Ma C, Schoepfer AM, Dellon ES, Bredenoord AJ, Chehade M, Collins MH, Feagan BG, Furuta GT, Gupta SK, Hirano I, Jairath V, Katzka DA, Pai RK, Rothenberg ME, Straumann A, Aceves SS, Alexander JA, Arva NC, Atkins D, Biedermann L, Blanchard C, Cianferoni A, Ciriza de Los Rios C, Clayton F, Davis CM, de Bortoli N, Dias JA, Falk GW, Genta RM, Ghaffari G, Gonsalves N, Greuter T, Hopp R, Hsu Blatman KS, Jensen ET, Johnston D, Kogalwalla AF, Larsson HM, Leung J, Louis H, Masterson JC, Menard-Katcher C, Menard-Katcher PA, Moawad FJ, Muir AB, Mukkada VA, Penagini R, Pesek RD, Peterson K, Putnam PE, Ravelli A, Savarino EV, Schlog C, Schreiner P, Simon D, Smyrk TC, Spergel JM, Taft TH, Terrehorst I, Vanuytsel T, Venter C, Vieira MC, Vieth M, Vlieg-Boerstra B, von Arnim U, Walker MM, Wechsler JB, Woodland P, Woosley JT, Yang GY, Zevit N, Safroneeva E (2021). Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS) PMID: 34242635. Clinical immunology (Orlando, Fla.),
  18. Peterson KA, Boynton K (2014). Which patients with eosinophilic esophagitis (EoE) should receive elemental diets versus other therapies?. Current gastroenterology reports, 16(1), 364.
  19. McClain A, O'Gorman M, Barbagelata C, Patel R, Lowichik A, Peterson K, Guthery S, Robson (2019). Adherence to Biopsy and Follow-Up Guidelines in a Population-Based Cohort of Children With Eosinophilic Esophagitis. Clinical gastroenterology and hepatology, 18(11), 2620-2622.
  20. Robson J, O'Gorman M, McClain A, Mutyala K, Davis C, Barbagelata C, Wheeler J, Firszt R, Smith K, Patel R, Peterson K, Lowichik A, Guthery (2019). Incidence and Prevalence of Pediatric Eosinophilic Esophagitis in Utah Based on a 5-Year Population-Based Study. Clinical gastroenterology and hepatology, 17(1), 107-114.e1.
  21. Dellon ES, Gonsalves N, Rothenberg ME, Hirano I, Chehade M, Peterson KA, Falk GW, Murray JA, Gehman LT, Chang AT, Singh B, Rasmussen HS, Genta R (2021). Determination of Biopsy Yield That Optimally Detects Eosinophilic Gastritis and/or Duodenitis in a Randomized Trial of Lirentelimab. Clinical gastroenterology and hepatology, 20(3), 535-545.e15.
  22. Peterson K, Safroneeva E, Schoepfer (2021). Emerging Therapies for Eosinophilic Gastrointestinal Diseases. The journal of allergy and clinical immunology. In practice,
  23. Youngblood BA, Brock EC, Leung J, Falahati R, Bochner BS, Rasmussen HS, Peterson K, Bebbington C, Tomasevic (2019). Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis. JCI insight, 4(19),
  24. Rothenberg ME, Hottinger SKB, Gonsalves N, Furuta GT, Collins MH, Talley NJ, Peterson K, Menard-Katcher C, Smith M, Hirano I, Genta RM, Chehade M, Gupta SK, Spergel JM, Aceves SS, Dellon E (2021). Impressions and aspirations from the FDA GREAT VI Workshop on Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis and Perspectives for Progress in the Field. The Journal of allergy and clinical immunology,
  25. Dellon ES, Peterson KA, Murray JA, Falk GW, Gonsalves N, Chehade M, Genta RM, Leung J, Khoury P, Klion AD, Hazan S, Vaezi M, Bledsoe AC, Durrani SR, Wang C, Shaw C, Chang AT, Singh B, Kamboj AP, Rasmussen HS, Rothenberg ME, Hirano (2020). Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis. The New England journal of medicine, 383(17), 1624-1634.
  26. Ma C, Bredenoord AJ, Dellon ES, Alexander JA, Biedermann L, Hogan M, Guizzetti L, Zou G, Katzka DA, Chehade M, Falk GW, Furuta GT, Gupta SK, Kagalwalla AF, Schoepfer AM, Miehlke S, Moawad FJ, Peterson K, Gonsalves NP, Straumann A, Wechsler JB, Rémillard J, Shackelton LM, Almonte HS, Feagan BG, Jairath V, Hirano (2022). Reliability and responsiveness of endoscopic disease activity assessment in eosinophilic esophagitis. Gastrointestinal endoscopy,
  27. Dellon ES, Gonsalves N, Abonia JP, Alexander JA, Arva NC, Atkins D, Attwood SE, Auth MKH, Bailey DD, Biederman L, Blanchard C, Bonis PA, Bose P, Bredenoord AJ, Chang JW, Chehade M, Collins MH, Di Lorenzo C, Dias JA, Dohil R, Dupont C, Falk GW, Ferreira CT, Fox AT, Genta RM, Greuter T, Gupta SK, Hirano I, Hiremath GS, Horsley-Silva JL, Ishihara S, Ishimura N, Jensen ET, Gutiérrez-Junquera C, Katzka DA, Khoury P, Kinoshita Y, Kliewer KL, Koletzko S, Leung J, Liacouras CA, Lucendo AJ, Martin LJ, McGowan EC, Menard-Katcher C, Metz DC, Miller TL, Moawad FJ, Muir AB, Mukkada VA, Murch S, Nhu QM, Nomura I, Nurko S, Ohtsuka Y, Oliva S, Orel R, Papadopoulou A, Patel DA, Pesek RD, Peterson KA, Philpott H, Putnam PE, Richter JE, Rosen R, Ruffner MA, Safroneeva E, Schreiner P, Schoepfer A, Schroeder SR, Shah N, Souza RF, Spechler SJ, Spergel JM, Straumann A, Talley NJ, Thapar N, Vandenplas Y, Venkatesh RD, Vieira MC, von Arnim U, Walker MM, Wechsler JB, Wershil BK, Wright BL, Yamada Y, Yang GY, Zevit N, Rothenberg ME, Furuta GT, Aceves S (2022). International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature. Clinical gastroenterology and hepatology,
  28. Ravi A, Marietta EV, Alexander JA, Peterson K, Lavey C, Geno DM, Murray JA, Katzka D (2021). Mucosal penetration and clearance of gluten and milk antigens in eosinophilic oesophagitis. Alimentary pharmacology & therapeutics, 53(3), 410-417.
  29. Dellon ES, Khoury P, Muir AB, Liacouras CA, Safroneeva E, Atkins D, Collins MH, Gonsalves N, Falk GW, Spergel JM, Hirano I, Chehade M, Schoepfer AM, Menard-Katcher C, Katzka DA, Bonis PA, Bredenoord AJ, Geng B, Jensen ET, Pesek RD, Feuerstadt P, Gupta SK, Lucendo AJ, Genta RM, Hiremath G, McGowan EC, Moawad FJ, Peterson KA, Rothenberg ME, Straumann A, Furuta GT, Aceves S (2022). A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions. Gastroenterology,
  30. Dellon ES, Khoury P, Muir AB, Liacouras CA, Safroneeva E, Atkins D, Collins MH, Gonsalves N, Falk GW, Spergel JM, Hirano I, Chehade M, Schoepfer AM, Menard-Katcher C, Katzka DA, Bonis PA, Bredenoord AJ, Geng B, Jensen ET, Pesek RD, Feuerstadt P, Gupta SK, Lucendo AJ, Genta RM, Hiremath G, McGowan EC, Moawad FJ, Peterson KA, Rothenberg ME, Straumann A, Furuta GT, Aceves S (2022). A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions. The Journal of allergy and clinical immunology,
  31. Ravi A, Marietta EV, Alexander JA, Peterson K, Lavey C, Geno DM, Murray JA, Katzka D (2021). Mucosal penetration and clearance of gluten and milk antigens in eosinophilic oesophagitis. Alimentary pharmacology & therapeutics, 53(3), 410-417.
  32. Peterson K, Lin E, Saffari H, Qeadan F, Pyne A, Firszt R, Robson J, Gleich (2020). Food-specific antibodies in oesophageal secretions: association with trigger foods in eosinophilic oesophagitis. Alimentary pharmacology & therapeutics, 52(6), 997-1007.
  33. Uchida AM, Ro G, Qiang L, Peterson KA, Round J, Dougan M, Dougan S (2022). Human differentiated eosinophils release IL-13 in response to IL-33 stimulation. Frontiers in immunology, 13, 946643.
  34. Allen-Brady K, Colletier KJ, Woller S, Eliason K, Uchida AM, Ro G, Newman M, Peterson K (2022). Eosinophilic Gastritis and Enteritis Are Increased in Families with Eosinophilic Esophagitis. The American journal of gastroenterology, 118(2), 263-268.
  35. Pyne AL, Hazel MW, Uchida AM, Qeadan F, Jordan KC, Holman A, Harward B, Gleich GJ, Peterson K (2022). Oesophageal secretions reveal local food-specific antibody responses in eosinophilic oesophagitis. Alimentary pharmacology & therapeutics, 56(9), 1328-1336.
  36. Chang JW, Kliewer K, Katzka DA, Peterson KA, Gonsalves N, Gupta SK, Furuta GT, Dellon E (2022). Provider beliefs, practices, and perceived barriers to dietary elimination therapy in eosinophilic esophagitis. The American journal of gastroenterology, 117(12), 2071-2074.
  37. Talley NJ, Peterson KA, Genta RM, Chang AT, Dellon ES, Sandborn WJ, 019 Study Tea (2022). High discovery rate of duodenal and gastric eosinophilia in patients with unexplained moderate-severe abdominal symptoms: A prospective US multi-site study. Gastroenterology, 164(4), 680-683.e2.
  38. Chang JW, Kliewer K, Katzka DA, Peterson KA, Gonsalves N, Gupta SK, Furuta GT, Dellon E (2022). Provider Beliefs, Practices, and Perceived Barriers to Dietary Elimination Therapy in Eosinophilic Esophagitis. The American journal of gastroenterology, 117(12), 2071-2074.
  39. Kliewer KL, Gonsalves N, Dellon ES, Katzka DA, Abonia JP, Aceves SS, Arva NC, Besse JA, Bonis PA, Caldwell JM, Capocelli KE, Chehade M, Cianferoni A, Collins MH, Falk GW, Gupta SK, Hirano I, Krischer JP, Leung J, Martin LJ, Menard-Katcher P, Mukkada VA, Peterson KA, Shoda T, Rudman Spergel AK, Spergel JM, Yang GY, Zhang X, Furuta GT, Rothenberg M (2023). One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial. The lancet. Gastroenterology & hepatology,
  40. Parbhu SK, Shah SC, Sossenheimer MJ, Fang JC, Peterson KA, Gawron A (2022). Index diagnoses of gastric intestinal metaplasia in the United States: patient characteristics, endoscopic findings, and clinical practice patterns at a large tertiary care center. Therapeutic advances in gastroenterology, 15, 17562848221117640.
  41. Qeadan F, Tingey B, Egbert J, Pezzolesi MG, Burge MR, Peterson KA, Honda (2022). The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: A nationwide cohort from the US using the Cerner Real-World Data. PloS one, 17(4), e0266809.
  42. Peterson K, Clayton F, Qeadan F, Gorman D, Robson J, Allen-Brady K, Fang J (2022). Esophageal Eosinophilia Is Common Among Relatives of Eosinophilic Esophagitis Patients. Clinical gastroenterology and hepatology, 20(5), e957-e963.
  43. Leiman DA, Kamal AN, Otaki F, Bredenoord AJ, Dellon ES, Falk GW, Fernandez-Becker NQ, Gonsalves N, Hirano I, Katzka DA, Peterson K, Yadlapati R, Kathpalia (2022). Quality Indicators for the Diagnosis and Management of Eosinophilic Esophagitis. The American journal of gastroenterology,
  44. DeLay K, Pandolfino JE, Gyawali CP, Frye J, Kaizer A, Menard-Katcher P, Sloan JA, Gawron AJ, Peterson K, Carlson DA, Khan A, Keswani RN, Yadlapati (2020). Esophageal Manometry Competency Program Improves Gastroenterology Fellow Performance in Motility Interpretation. The American journal of gastroenterology, 115(9), 1453-1459.
  45. Reddy CA, Allen-Brady K, Uchida AM, Peterson KA, Hoffman AM, Souza RF, Spechler S (2023). Achalasia is Strongly Associated with Eosinophilic Esophagitis and Other Allergic Disorders. Clinical gastroenterology and hepatology, 22(1), 34-41.e2.
  46. Toy G, Colletier K, Hale G, Valentine J, Gawron AJ, Sossenheimer M, Peterson K, Aparicio R, Fang J (2023). Incidence of retained biopsy specimens after esophagogastroduodenoscopy and colonoscopy. Endoscopy international open, 11(7), E653-E659.
  47. Dellon ES, Peterson KA, Mitlyng BL, Iuga A, Bookhout CE, Cortright LM, Walker KB, Gee TS, McGee SJ, Cameron BA, Galanko JA, Woosley JT, Eluri S, Moist SE, Hirano (2023). Mepolizumab for treatment of adolescents and adults with eosinophilic oesophagitis: a multicentre, randomised, double-blind, placebo-controlled clinical trial. Gut, 72(10), 1828-1837.
  48. Dellon ES, Peterson KA, Mitlyng BL, Iuga A, Bookhout CE, Cortright LM, Walker KB, Gee TS, McGee SJ, Cameron BA, Galanko JA, Woosley JT, Eluri S, Moist SE, Hirano (2023). Mepolizumab for treatment of adolescents and adults with eosinophilic oesophagitis: a multicentre, randomised, double-blind, placebo-controlled clinical trial. Gut, 72(10), 1828-1837.
  49. Reddy CA, Allen-Brady K, Uchida AM, Peterson KA, Hoffman AM, Souza RF, Spechler S (2024). Achalasia is Strongly Associated With Eosinophilic Esophagitis and Other Allergic Disorders. Clinical gastroenterology and hepatology, 22(1), 34-41.e2.
  50. Kim S, Morgenstern NB, Osonoi K, Aceves SS, Arva NC, Chehade M, Collins MH, Dellon ES, Falk GW, Furuta GT, Gonsalves NP, Gupta SK, Hirano I, Hiremath G, Katzka DA, Khoury P, Leung J, Pesek R, Peterson KA, Pletneva M, Spergel JM, Wechsler JB, Yang GY, Rothenberg ME, Shoda (2024). Non-epithelial Gene Expression Correlates with Symptom Severity in Adults with Eosinophilic Esophagitis. The journal of allergy and clinical immunology. In practice,
  51. Sato H, Dellon ES, Aceves SS, Arva NC, Chehade M, Collins MH, Davis CM, Falk GW, Furuta GT, Gonsalves NP, Gupta SK, Hirano I, Hiremath G, Katzka DA, Khoury P, Leung J, Menard-Katcher P, Pesek R, Peterson KA, Pletneva MA, Spergel JM, Wechsler JB, Yang GY, Rothenberg ME, Shoda (2024). Clinical and molecular correlates of the Index of Severity for Eosinophilic Esophagitis. The Journal of allergy and clinical immunology,
  52. Chehade M, Wright BL, Walsh S, Bailey DD, Muir AB, Klion AD, Collins MH, Davis CM, Furuta GT, Gupta S, Khoury P, Peterson KA, Jensen E (2024). Challenging assumptions about the demographics of eosinophilic gastrointestinal diseases: A systematic review. The journal of allergy and clinical immunology. Global, 3(3), 100260.
  53. Rothenberg ME, Dellon ES, Collins MH, Bredenoord AJ, Hirano I, Peterson KA, Brooks L, Caldwell JM, Fjällbrant H, Grindebacke H, Ho CN, Keith M, McCrae C, Sinibaldi D, White WI, Datto CJ, MESSINA Trial Investigator (2024). Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis. The New England journal of medicine, 390(24), 2252-2263.
  54. Pyne AL, Uchida AM, Hazel MW, Stubben CJ, Chang JW, Bailey DD, Gonsalves N, Allen-Brady K, Peterson KA, Pletneva M (2024). Effect of benralizumab on histopathology and inflammatory signatures in a clinical cohort of eosinophilic esophagitis. Diseases of the esophagus,
  55. Pyne AL, Schuman SS, Brintz BJ, Dodds W, Silon B, Pletneva MA, Peterson K (2025). Inflammatory Markers in Gastric Fluids Differentiate Patients With Eosinophilic Gastritis: Search for a Disease Screener. Clinical and translational gastroenterology, 16(10), e00898.

Review

  1. Chang JW, Kliewer K, Haller E, Lynett A, Doerfler B, Katzka DA, Peterson KA, Dellon ES, Gonsalves N, Consortium of Eosinophilic Gastrointestinal Disease Researcher (2023). Development of a practical guide to implement and monitor diet therapy for eosinophilic esophagitis. Clinical gastroenterology and hepatology,
  2. Uchida AM, Ro G, Garber JJ, Peterson KA, Round J (2022). Models and Tools for Investigating Eosinophilic Esophagitis at the Bench. Frontiers in immunology, 13, 943518.

Conference Proceedings

  1. Ma C, Schoepfer AM, Safroneeva E, COREOS Collaborators., COREOS Collaborators (2021). Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS): An International Multidisciplinary Consensus. Gastroenterology, 161(3), 748-755.
  2. Ma C, Schoepfer AM, Safroneeva E, COREOS Collaborators., COREOS Collaborators (2021). Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS): An International Multidisciplinary Consensus. Gastroenterology, 161(3), 748-755.

Commentary

  1. Ma C, Schoepfer AM, Safroneeva E, COREOS Collaborators (2021). A Summary of the Meetings of the Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS) International Multidisciplinary Consensus. Gastroenterology, 161(3), 778-784.
  2. Ma C, Schoepfer AM, Safroneeva E, COREOS Collaborators (2021). A Summary of the Meetings of the Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS) International Multidisciplinary Consensus. Gastroenterology, 161(3), 778-784.

Editorial

  1. Gupta SK, Falk GW, Aceves SS, Chehade M, Collins MH, Dellon ES, Gonsalves N, Hirano I, Mukkuda VA, Peterson KA, Spergel J, Yang GY, Furuta GT, Rothenberg ME, Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) (2019). Consortium of Eosinophilic Gastrointestinal Disease Researchers: Advancing the Field of Eosinophilic GI Disorders Through Collaboration. Gastroenterology, 156(4), 838-842.

Letter

  1. May Maestas M, Perry KD, Smith K, Firszt R, Allen-Brady K, Robson J, Joy E, Peterson K (2019). Food impactions in Eosinophilic esophagitis and acute exposures to fine particulate pollution. [Letter to the editor]. Allergy, 74(12), 2529-2530.
  2. Spechler SJ, Reddy CA, Allen-Brady K, Uchida AM, Peterson KA, Hoffman AM, Souza R (2023). Reply. Clinical gastroenterology and hepatology,

Other

  1. Qeadan F, Chehade M, Tingey B, Egbert J, Dellon ES, Peterson K (2021). Patients with eosinophilic gastrointestinal disorders have lower in-hospital mortality rates related to COVID-19. The journal of allergy and clinical immunology. In practice, 9(12), 4473-4476.e4.
  2. Saffari H, Peterson KA, Leiferman KM, Stabin MG, Krstyen JJ, Clayton FC, Pease LF 3rd, Yap JT, Hoffman JM, Gleich G (2020). Oral Administration of 99mTechnetium-Labeled Heparin in Eosinophilic Esophagitis. Mayo Clinic proceedings, 95(3), 449-458.
  3. Hirano I, Collins MH, King E, Sun Q, Chehade M, Abonia JP, Bonis PA, Capocelli KE, Dellon ES, Falk GW, Gonsalves N, Gupta SK, Leung J, Katzka D, Menard-Katcher P, Khoury P, Klion A, Mukkada VA, Peterson K, Shoda T, Rudman-Spergel AK, Spergel JA, Yang GY, Rothenberg ME, Aceves SS, Furuta GT, CEGIR investigators (2022). Prospective Endoscopic Activity Assessment for Eosinophilic Gastritis in a Multisite Cohort. The American journal of gastroenterology, 117(3), 413-423.
  4. COREOS Collaborators:., Ma C, Schoepfer AM, Dellon ES, Bredenoord AJ, Chehade M, Collins MH, Feagan BG, Furuta GT, Gupta SK, Hirano I, Jairath V, Katzka DA, Pai RK, Rothenberg ME, Straumann A, Aceves SS, Alexander JA, Arva NC, Atkins D, Biedermann L, Blanchard C, Cianferoni A, Ciriza de Los Rios C, Clayton F, Davis CM, de Bortoli N, Dias JA, Falk GW, Genta RM, Ghaffari G, Gonsalves N, Greuter T, Hopp R, Hsu Blatman KS, Jensen ET, Johnston D, Kagalwalla AF, Larsson HM, Leung J, Louis H, Masterson JC, Menard-Katcher C, Menard-Katcher PA, Moawad FJ, Muir AB, Mukkada VA, Penagini R, Pesek RD, Peterson K, Putnam PE, Ravelli A, Savarino EV, Schlag C, Schreiner P, Simon D, Smyrk TC, Spergel JM, Taft TH, Terreehorst I, Vanuytsel T, Venter C, Vieira MC, Vieth M, Vlieg-Boerstra B, von Arnim U, Walker MM, Wechsler JB, Woodland P, Woosley JT, Yang GY, Zevit N, Safroneeva (2022). Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS). The Journal of allergy and clinical immunology, 149(2), 659-670.
  5. Aceves SS, Alexander JA, Baron TH, Bredenoord AJ, Day L, Dellon ES, Falk GW, Furuta GT, Gonsalves N, Hirano I, Konda VJA, Lucendo AJ, Moawad F, Peterson KA, Putnam PE, Richter J, Schoepfer AM, Straumann A, McBride DL, Sharma P, Katzka D (2022). Endoscopic approach to eosinophilic esophagitis: American Society for Gastrointestinal Endoscopy Consensus Conference. Gastrointestinal endoscopy,
  6. Chen JW, Vela MF, Peterson KA, Carlson D (2023). AGA Clinical Practice Update on the Diagnosis and Management of Extraesophageal Gastroesophageal Reflux Disease: Expert Review. Clinical gastroenterology and hepatology, 21(6), 1414-1421.e3.